MKI67 and breast carcinoma: Strengths of our study include analysis of normal breast tissues from women without any history of breast cancer, quantitative measures of breast tissue composition, ER, PR and Ki-67 expression, use of standardised and optimised sample collection procedures, and a rich collection of epidemiologic data through the Karma cohort.